Xeris Biopharma Holdings, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Chicago, IL
XERS chart
What traders are saying about $XERS
Latest postsXeris Biopharma Holdings, Inc. news
- Xeris Biopharma Holdings (XERS) Could Be 17% Undervalued On New Clinical Data
Simply Wall Street ·
- Can Corcept Therapeutics Stock Rally 40% After This Dip?
trefis.com ·
- Why Xeris Biopharma Holdings (XERS) Is Down 6.1% And What's Next
Simply Wall Street ·
- Xeris Biopharma issued notice of allowance from USPTO for XP-8121
TipRanks ·
- Xeris Biopharma Holdings Inc (XERS) Stock Down 6.1% but Still Ov
GuruFocus ·
- Xeris Biopharma stock: Xeris schedules November 5 results for Xeris Biopharma stock
ad-hoc-news.de ·
- Xeris Biopharma Holdings, Inc. Estimates – NASDAQ:XERS
TradingView ·
- Xeris Biopharma to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
Yahoo Finance ·
- Xeris Biopharma Reinforces Leadership in Endocrinology With Data Disclosures Spanning Commercial Portfolio and Pipeline at Multiple Scientific Meetings
Yahoo Finance ·
- Why Xeris Biopharma Holdings (XERS) Is Up 5.8% After Raising 2026 Revenue Guidance And Retiring Debt
Yahoo Finance ·
- Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance ·
- Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports
Yahoo Finance ·
Xeris Biopharma Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $291.8M | $203.1M | $163.9M | $110.2M |
| Net income | $554,000 | -$54.8M | -$62.3M | -$94.7M |
| Diluted EPS | $0.00 | $-0.37 | $-0.45 | $-0.70 |
| Total assets (year end) | $383.5M | $323.1M | $322.6M | $344.5M |
| Cash and equivalents (year end) | $111.0M | $71.6M | $67.4M | $122.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Xeris Biopharma Holdings, Inc.
- Ticker
- XERS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Chicago, IL
- Fiscal year end
- December 31
- SEC CIK
- 1867096
Frequently asked questions
What exchange is Xeris Biopharma Holdings, Inc. listed on?
Xeris Biopharma Holdings, Inc. trades on the Nasdaq under the ticker symbol XERS.
What industry is Xeris Biopharma Holdings, Inc. in?
Xeris Biopharma Holdings, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Xeris Biopharma Holdings, Inc. headquartered?
Xeris Biopharma Holdings, Inc.'s business address on file with the SEC is in Chicago, IL.
When does Xeris Biopharma Holdings, Inc.'s fiscal year end?
Xeris Biopharma Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Xeris Biopharma Holdings, Inc. report?
Xeris Biopharma Holdings, Inc. reported $291.8M in revenue for calendar year 2025, according to its SEC filings.